ArticleFrontiers in neuroscience2025
Evolution of spinal evoked compound action potential thresholds, visual motor thresholds, and impedances in a rodent spared nerve injury model.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The mechanisms of spinal cord stimulation (SCS) on neuropathic pain are commonly studied using the spared nerve injury (SNI) model, with stimulation amplitudes typically programed relative to the visual motor threshold (vMT). Recent work explored the relationship between vMTs and spinal evoked compound action potential thresholds (ECAPTs)-a sensed measure of neural activation-in SNI rodents to better translate towards clinical dosing. However, changes across chronic healing beyond two days and pain states is unknown. Methods: This study tracked ECAPs through a traditional SNI-SCS approach, where nine rats were implanted with an SCS lead to evaluate effects of acute healing (days 0 to 1), chronic healing (days 1 to 7), nerve injury (days 7 to 14), and continuous SCS (days 14 to 16) using differential target multiplexed programing (DTMP). Results: ECAPT:vMT ratios significantly increased on subsequent recordings from day 0 through day 14 (i.e., post-injury), but not between days 14 and 16 (after SCS), across anesthesia states, or SCS pulse widths. On average, ECAPT:vMT increased from 35 ± 2% (mean ± S.E.) on implantation day to 54 ± 1% on day 16. Discussion: Future studies may use this approach to further elucidate the effects of chronic pain and SCS on the spinal ECAP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.